International funderBased in Netherlands

Lareb

NetherlandsWebsite

About Lareb

Lareb is the Dutch center for reporting and knowledge on adverse effects of medicines, vaccines, and health products, and its giving is tightly aligned with that mission. Its support focuses on encouraging research, education, and student engagement around medication safety, pharmacovigilance, and the methods used to monitor and study side effects. The funder appears to prioritize Dutch university students and academic work that advances drug safety knowledge in a practical, field-building way.

Focus Areas

Pharmacovigilance ResearchAdverse Drug Reaction ReportingMedicine and Vaccine SafetyClinical Pharmacology EducationStudent Theses on Drug SafetyMethods of Pharmacovigilance

Giving Approach

Small, targeted support through an open thesis-printing subsidy and an annual prize; one program accepts applications year-round, while the student award has a fixed yearly deadline. Grants appear modest and program-specific rather than large, multi-year commitments.

How to approach this funder

For the thesis subsidy, applications can be submitted at any time and should clearly show relevance to adverse effects, pharmacovigilance methods, or education about drug side effects. For the Leopold Meijler Prize, submit by 1 October each year and ensure the candidate is a student in Medicine, Pharmacy, or Health Sciences at a Dutch university.

Want a Personalized Pitch for Lareb?

Get Started Free View Pricing

Free plan available

No contracts

Cancel anytime

Lareb

About Lareb

Focus Areas

Giving Approach

How to approach this funder

Want a Personalized Pitch for Lareb?

Notable grantees:

Open Grant Opportunities

Subsidie proefschrift (Leopold Meijler Fonds)

Lareb

About Lareb

Focus Areas

Giving Approach

How to approach this funder

Want a Personalized Pitch for Lareb?

The Grant Brief

Notable grantees:

Open Grant Opportunities

Subsidie proefschrift (Leopold Meijler Fonds)